Skip to main content
A headshot of Daniel Grossman

Daniel Grossman, MD

ANSIRH Director

Daniel Grossman, MD, is ANSIRH's Director. He focuses his research on both clinical and social science studies aimed at improving access to contraception and safe abortion in the United States, Latin America, and sub-Saharan Africa, as well as evaluating the impact of integrating reproductive health and HIV services. He has served on committees for professional organizations such as the American Public Health Association and the American College of Obstetricians and Gynecologists. As a faculty member in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF, Dr. Grossman performs clinical work at Zuckerberg San Francisco General Hospital. He is also a Senior Advisor with Ibis Reproductive Health. Dr. Grossman received his Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University and an MD from Stanford University. He completed his residency in Obstetrics and Gynecology at UCSF.

The latest research

See all
March 26, 2025

No-Test Screening Protocols May Disproportionately Exclude Structurally Oppressed Communities Who Could Benefit from Accessing Medication Abortion

Biggs MA, Ralph LJ, Ehrenreich K, Kaller S, Blanchard K, Hauser D, Kapp N, Kromenaker T, Moayedi G, Perritt J, Raymond EG, Kari White, Grossman D. No-Test Screening Protocols May Disproportionately Exclude Structurally Oppressed Communities Who Could Benefit from Accessing Medication Abortion. Health Equity. March 2025; https://doi.org/10.1089/heq.2024.0128.
February 27, 2025

Factors associated with severe pain during medication abortion at ≤9 weeks’ gestation: A secondary analysis of a multicenter, randomized, placebo-controlled trial

Loeliger KB, Dragoman MV, Kapp N, Tamang A, Bessenaar T, Dung DL, Gautam J, Yoko JL, Minh NH, Grossman D. Factors associated with severe pain during medication abortion at ≤9 weeks’ gestation: A secondary analysis of a multicenter, randomized, placebo-controlled trial. Contraception. February 2025; https://doi.org/10.1016/j.contraception.2025.110859.